United States · FDA National Drug Code directory
Alfuzosin Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 84386-153_8811cb59-6826-41d5-ab68-567338a4b883
- Product NDC
- 84386-153
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Composition / generic term
- Alfuzosin Hydrochloride
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260701
- Source listing expiry
- 20271231
Source-listed ingredients
- ALFUZOSIN HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (84386-153-01) · 84386-153-01
- 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (84386-153-05) · 84386-153-05
- 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (84386-153-30) · 84386-153-30
- 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (84386-153-90) · 84386-153-90
- 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (84386-153-99) · 84386-153-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →